308 related articles for article (PubMed ID: 6144973)
1. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
[TBL] [Abstract][Full Text] [Related]
2. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
[No Abstract] [Full Text] [Related]
3. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.
Barré-Sinoussi F; Mathur-Wagh U; Rey F; Brun-Vezinet F; Yancovitz SR; Rouzioux C; Montagnier L; Mildvan D; Chermann JC
JAMA; 1985 Mar 22-29; 253(12):1737-9. PubMed ID: 2983130
[TBL] [Abstract][Full Text] [Related]
4. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay.
Biberfeld G; Bredberg-Råden U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
Scand J Immunol; 1985 Mar; 21(3):289-92. PubMed ID: 2986278
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men.
Mathur-Wagh U; Mildvan D; Spigland I; Brun-Vezinet F; Barre-Sinoussi F; Montagnier L; Chermann JC
Adv Exp Med Biol; 1985; 187():93-6. PubMed ID: 2994424
[No Abstract] [Full Text] [Related]
7. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L
N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
[TBL] [Abstract][Full Text] [Related]
12. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
Abb J
Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
14. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
15. Unexplained lymphadenopathy in homosexual men. A longitudinal study.
Fishbein DB; Kaplan JE; Spira TJ; Miller B; Schonberger LB; Pinsky PF; Getchell JP; Kalyanaraman VS; Braude JS
JAMA; 1985 Aug; 254(7):930-5. PubMed ID: 2991618
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Lancet; 1984 Nov; 2(8411):1094. PubMed ID: 6150160
[No Abstract] [Full Text] [Related]
18. Human T cell leukemia virus-1 antibodies not detected in AIDS.
Purtilo DT; Lipscomb H; Harada S; Tatsumi E; Hinuma Y; Karpas A; Sonnabend J
AIDS Res; 1983-1984; 1(4):237-41. PubMed ID: 6152820
[TBL] [Abstract][Full Text] [Related]
19. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).
Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F
J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features.
Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH
Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
